Dumont & Blake Investment Advisors LLC Sells 1,732 Shares of Unum Group (NYSE:UNM)

Dumont & Blake Investment Advisors LLC trimmed its stake in Unum Group (NYSE:UNM) by 13.4% during the fourth quarter, Holdings Channel reports. The fund owned 11,190 shares of the financial services provider’s stock after selling 1,732 shares during the quarter. Dumont & Blake Investment Advisors LLC’s holdings in Unum Group were worth $817,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the company. Versant Capital Management Inc grew its position in Unum Group by 26.4% in the 4th quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock worth $56,000 after purchasing an additional 160 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in shares of Unum Group by 28.8% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 800 shares of the financial services provider’s stock worth $58,000 after acquiring an additional 179 shares in the last quarter. CIBC Asset Management Inc increased its stake in shares of Unum Group by 3.4% in the third quarter. CIBC Asset Management Inc now owns 5,551 shares of the financial services provider’s stock valued at $330,000 after buying an additional 180 shares in the last quarter. V Square Quantitative Management LLC lifted its position in shares of Unum Group by 38.2% during the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock worth $42,000 after purchasing an additional 194 shares in the last quarter. Finally, Brooklyn Investment Group increased its stake in shares of Unum Group by 3.1% in the 3rd quarter. Brooklyn Investment Group now owns 6,592 shares of the financial services provider’s stock valued at $392,000 after buying an additional 197 shares during the period. 86.57% of the stock is owned by institutional investors.

Insider Buying and Selling at Unum Group

In related news, CAO Walter Lynn Rice, Jr. sold 1,500 shares of the company’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $69.56, for a total transaction of $104,340.00. Following the sale, the chief accounting officer now owns 8,361 shares of the company’s stock, valued at $581,591.16. This represents a 15.21 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Timothy Gerald Arnold sold 10,000 shares of Unum Group stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $76.92, for a total transaction of $769,200.00. Following the transaction, the executive vice president now directly owns 54,827 shares of the company’s stock, valued at $4,217,292.84. The trade was a 15.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 102,914 shares of company stock valued at $7,677,945. Insiders own 0.93% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on UNM. JPMorgan Chase & Co. restated a “neutral” rating and set a $79.00 price objective (up previously from $74.00) on shares of Unum Group in a report on Tuesday, January 7th. UBS Group upgraded shares of Unum Group to a “hold” rating in a report on Wednesday, October 9th. Bank of America boosted their price objective on shares of Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a report on Thursday, October 10th. Truist Financial boosted their price target on Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, Piper Sandler lifted their price target on Unum Group from $74.00 to $82.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Five analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $76.75.

Unum Group Stock Performance

Unum Group stock opened at $77.07 on Friday. The firm has a fifty day simple moving average of $74.22 and a two-hundred day simple moving average of $64.36. Unum Group has a twelve month low of $46.39 and a twelve month high of $77.69. The company has a market capitalization of $14.07 billion, a PE ratio of 8.34, a P/E/G ratio of 1.09 and a beta of 0.81. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32.

Unum Group (NYSE:UNM) last issued its quarterly earnings results on Tuesday, October 29th. The financial services provider reported $2.13 EPS for the quarter, topping analysts’ consensus estimates of $2.10 by $0.03. The firm had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.26 billion. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.94 EPS. Research analysts expect that Unum Group will post 8.54 EPS for the current year.

Unum Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 24th will be issued a dividend of $0.42 per share. The ex-dividend date is Friday, January 24th. This represents a $1.68 annualized dividend and a dividend yield of 2.18%. Unum Group’s payout ratio is 18.18%.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.